HIND Vyome Holdings, Inc. Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

HIND — —
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
18
List Date
2025-08-15
CIK
0001427570
Next Earnings
2026-11-13
Headquarters
San Clemente, CA
Homepage
https://vyometx.com

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of …

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'25'26Avg
Jan---45.92%-45.92%
Feb--53.18%53.18%
Mar---36.95%-36.95%
Apr---5.58%-5.58%
May--19.39%19.39%
Jun---7.33%-7.33%
Jul---3.86%-3.86%
Aug-34.29%-0.22%-17.25%
Sep-39.31%-11.06%-25.19%
Oct10.00%-10.94%*-0.47%
Nov-17.91%---17.91%
Dec-30.43%---30.43%
Total-74.95%-58.54%-66.74%
* Only 2 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.92
SMA 50: $2.04
SMA 200: $2.27
Current: $1.71
EMA 12: $1.86
EMA 26: $1.93
MACD: -0.0733 | Signal: -0.0190
BEARISH
ADX (14): 13.03
RANGE
+DI: 19.10
−DI: 23.99

Momentum Oscillators

RSI (14): 27.53
OVERSOLD
Stoch %K: 9.60
Stoch %D: 10.25
Williams %R: -97.66

Volume & Volatility

BB Upper: $2.12
BB Lower: $1.73
OVERSOLD
OBV: 58,210,706
Vol SMA 20: 9,751
Vol ROC: 136.96%
ATR: $0.09
True Range: $0.17
HV 20: 39.5%
HV 30: 48.7%
HV 60: 41.4%

Data Summary

Data Points: 301
Last Updated:
Date Range: 2025-08-15T00:00:00 – 2026-10-26T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All HIND news →

HIND Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 1.1398
Alpha: -103.15%
Correlation: 0.1911
R-Squared: 3.7%
Stock Volatility: 76.0%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Notable investors who own HIND
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$56K
0.00%
#5974 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

HIND Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

13 filers150,235 shares$338.46K value
# Filer Shares Value % of Total % of Float Period
1 Citadel Advisors LLC Custodian 25,972 $55.84K 16.50% — 2026-06-30
2 Geode Capital Management, LLC Custodian 25,793 $55.45K 16.38% — 2026-06-30
3 HRT FINANCIAL LP 20,318 $43.00K 12.70% — 2026-06-30
4 Vanguard Group Inc Custodian 12,195 $41.95K 12.39% — 2025-12-31
5 Focus Partners Wealth 14,640 $31.48K 9.30% — 2026-06-30
6 Vanguard Fiduciary Trust Co 12,195 $26.22K 7.75% — 2026-06-30
7 UBS Group AG Custodian 11,908 $25.60K 7.56% — 2026-06-30
8 Susquehanna International Group, LLP Custodian 10,058 $21.62K 6.39% — 2026-06-30
9 Vanguard Capital Management LLC 9,463 $20.34K 6.01% — 2026-06-30
10 Royal Bank of Canada Custodian 5,856 $13.00K 3.84% — 2026-06-30
11 Tower Research Capital LLC (TRC) Custodian 1,808 $3.89K 1.15% — 2026-06-30
12 Barclays PLC Custodian 26 $56 0.02% — 2026-06-30
13 Caitong International Asset Management Co., Ltd 3 $6 <0.01% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

HIND Insider Trading (Form 4)

Latest: 2026-09-03
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-03 Mohanjit Jolly Director Grant (A) +120,000 opt — EDGAR
2025-11-19 Stanley D Pomichter III Director Grant (A) +17,833 opt — EDGAR
2025-11-18 Mohanjit Jolly Director Award (A) +454,456 — EDGAR
2025-11-17 Venkateswarlu Nelabhotla President and CEO Grant (A) +615,149 opt — EDGAR
2025-11-17 John M. Tincoff III Director Grant (A) +17,833 opt — EDGAR
2025-11-17 Shiladitya Sengupta Director Grant (A) +624,432 opt — EDGAR
2025-09-22 Venkateswarlu Nelabhotla President and CEO Award (A) +7 — EDGAR
2025-09-11 Robert Dickey IV Chief Financial Officer Award (A) +762 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

HIND Insider Holdings

3 insiders · @ $1.71
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Mohanjit Jolly Director 454,456 $777.1K $0 2 2026-09-03
2 Robert Dickey IV Chief Financial Officer 762 $1.3K $0 1 2025-09-11
3 Venkateswarlu Nelabhotla President and CEO 7 $12 $0 2 2025-11-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

HIND Board & Officers

As of SEC filings through Sep 3, 2026

Directors 5

Officers 2

Changes in the last 10 years (53)
Sep 1, 2026Jerry Leonard became Chief Financial Officer
Aug 25, 2026The company announced the departure of Robert Dickey IV as Chief Financial Officer in an SEC filing
Aug 15, 2025Venkateswarlu Nelabhotla became a director
Aug 15, 2025Venkateswarlu Nelabhotla became President and CEO
Aug 15, 2025Stanley D Pomichter III became a director
Aug 15, 2025Shiladitya Sengupta became a director
Aug 15, 2025Robert Dickey IV became Chief Financial Officer
Aug 15, 2025Mohanjit Jolly became a director
Aug 15, 2025John M. Tincoff III became a director
Aug 13, 2025The company announced the departure of Thomas Stankovich as Chief Financial Officer in an SEC filing
Jan 5, 2024Yair Schneid became a 10% owner
Aug 15, 2022Paul F. Hickey became a director
Aug 15, 2022Paul F. Hickey became President and CEO
Jul 27, 2022The company announced the departure of Barton P. Bandy from the board in an SEC filing
Jul 27, 2022The company announced the departure of Barton P. Bandy as President and CEO in an SEC filing
Sep 17, 2021Barton P. Bandy first listed as President and CEO in an SEC filing
Aug 24, 2021Thomas Stankovich no longer listed as a director in SEC filings
Jun 29, 2021Steven Boyd reported in an SEC filing no longer being a 10% owner
Jun 29, 2021Armistice Capital, LLC reported in an SEC filing no longer being a 10% owner
Jun 15, 2021Thomas Stankovich became a director
Not reported recently (35)
  • Lori Courtney McDougal · Last reported as a director in an SEC filing dated Feb 23, 2024
  • Dan W Gladney · Last reported as a director in an SEC filing dated Feb 23, 2024
  • Yair Schneid · Last reported as a 10% owner in an SEC filing dated Jan 16, 2024
  • Paul F. Hickey · Last reported as a director in an SEC filing dated Dec 14, 2022
  • Arda Phd Minocherhomjee · Last reported as a director in an SEC filing dated Sep 17, 2021
  • Gary Blackford · Last reported as a director in an SEC filing dated Sep 17, 2021
  • Kim P. Kamdar · Last reported as a director in an SEC filing dated Sep 18, 2020
  • Sharon Stevenson · Last reported as a director in an SEC filing dated Sep 18, 2020
  • William J. Plovanic · Last reported as a director in an SEC filing dated Sep 18, 2020
  • Lesley H Howe · Last reported as a director in an SEC filing dated Sep 18, 2020
  • Raymond V Dittamore · Last reported as a director in an SEC filing dated Sep 18, 2020
  • Douglas Fisher · Last reported as a director in an SEC filing dated Sep 18, 2020
  • Andrew P Rasdal · Last reported as a director in an SEC filing dated Jun 25, 2020
  • Nooshin Hussainy · Last reported as Chief Financial Officer in an SEC filing dated Jun 25, 2020
  • Amy VandenBerg · Last reported as Chief Clinical & Reg Officer in an SEC filing dated Jan 28, 2020
  • Mark Brister · Last reported as Chief Technology Officer in an SEC filing dated Jan 28, 2020
  • Robert J MacDonald · Last reported as Chief Retail Officer in an SEC filing dated Jan 28, 2020
  • Brian H Dovey · Last reported as a 10% owner in an SEC filing dated Aug 8, 2019
  • Brian K Halak · Last reported as a 10% owner in an SEC filing dated Aug 8, 2019
  • Jesse I Treu · Last reported as a 10% owner in an SEC filing dated Aug 8, 2019
  • James C Blair · Last reported as a 10% owner in an SEC filing dated Aug 8, 2019
  • Nicole Vitullo · Last reported as a 10% owner in an SEC filing dated Aug 8, 2019
  • Domain Parters Vii L P · Last reported as a 10% owner in an SEC filing dated Aug 8, 2019
  • David Moatazedi · Last reported as a director in an SEC filing dated Jul 25, 2019
  • Donald R Young · Last reported as VP of Quality Assurance in an SEC filing dated Jan 4, 2019
  • Neil Drake · Last reported as VP Research and Development in an SEC filing dated Jan 4, 2019
  • Kelly Huang · Last reported as Chief Operating Officer in an SEC filing dated Jan 4, 2019
  • Robert H Mondore Jr · Last reported as VP of Operations in an SEC filing dated Jan 4, 2019
  • Daina Schmidt · Last reported as Vice President of Marketing in an SEC filing dated Oct 16, 2018
  • Todd Michael Wood · Last reported as Vice President of Sales in an SEC filing dated Aug 27, 2018
  • Jonah Shacknai · Last reported as a director in an SEC filing dated Jun 14, 2018
  • Matthew Norwood · Last reported as VP of Sales in an SEC filing dated Jan 4, 2018
  • Lisa Metzner · Last reported as VP of Marketing in an SEC filing dated Jan 4, 2018
  • Steven Ernest Johnson · Last reported as VP of Operations in an SEC filing dated Nov 2, 2017
  • Erin Morisey · Last reported as VP Strategic Partnerships in an SEC filing dated May 2, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
1 ETF hold HIND
1 shown · $28.81K total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VXF Vanguard Extended Market ETF Vanguard 0.00% $28,809 — 2026-09-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.